WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology… WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSW...
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology… WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSW...
